Cancer deaths higher in Greater Manchester compared to rest of UK

February 6, 2014 by Jane Bullock

Every day 18 people die from cancer in Greater Manchester – around 6,500 a year – making the death toll around 10 per cent higher than the UK average, according to the latest figures published by Cancer Research UK - part of Manchester Cancer Research Centre - today (Wednesday).

The main reason for the higher death rates is that that people in Greater Manchester are more likely to be diagnosed with cancer compared to the UK average, with rates of cancer cases also around 10 per cent higher.* This is likely to be partly due to higher numbers smoking in the city, smoking rates are around seven per cent higher than the national average.

Smoking causes more than eight in 10 lung cancer cases and overall two in 10 of all cancer cases.

Lung cancer is the most common cause of cancer death in Greater Manchester, with around 930 men and 790 women dying from the disease every year in the area.

Bowel and breast cancers are the next biggest cancer killers – around 320 men and 270 women die from in the city every year. And 420 women die from in Greater Manchester every year.

But, the good news is, survival rates from cancer continue to improve. Even though more people are getting cancer, thanks to better treatments and earlier diagnosis more people are surviving the disease than ever before.

Across Greater Manchester, each year around 1,100 men and 970 women are diagnosed with lung cancer. Around 1,900 women are diagnosed with breast cancer and 850 men and 670 women are diagnosed with bowel cancer.

Allan Jordan, who is Head of Chemistry at the Drug Discovery Unit at the Cancer Research UK Manchester Institute, part of The University of Manchester, said: "It's extremely worrying to see that you're more likely to die from cancer if you live in Manchester compared to other parts of the country. The latest stats show that lung cancer causes the most deaths from the disease in Greater Manchester. We must do more to tackle this by helping to reduce the number of people smoking as well as improving treatments, and diagnosing the disease earlier, when treatment is most likely to be effective."

"A major focus of the new Manchester Cancer Research Centre (MCRC) building will be finding new, personalised treatments for many types of cancers, and is a critical area of research for us. Our ambition is to be able to tailor treatments to the individual, targeting specific faults in their tumour and reducing side-effects of treatment."

The Manchester Cancer Research Centre (MCRC), which is being built in Withington, is being funded by Cancer Research UK, The University of Manchester and The Christie. All three organisations have worked closely together under the umbrella of "Manchester Cancer Research Centre" since 2006, but the new building, which is due for completion this summer, will provide an opportunity to work collaboratively under the same roof.

The "More Tomorrows" fundraising campaign will raise the remaining £5million needed to complete the new research centre, which will be the largest of its kind in Europe.

Nell Barrie, Senior Science Information Manager at Cancer Research UK, said: "These figures are a stark reminder that we must do more to ensure no-one dies prematurely of cancer. It's only through research that we will be able to beat cancer. We need to do more work to understand what drives the disease and how we can prevent it, as well as developing new treatments to reduce the number of people who die from it."

Allan Jordan added: "While the actual statistics are troubling, we must not lose sight of the fact that the numbers themselves are comprised of many individuals and their families, suffering from the effects of , who urgently need access to better treatments. At Cancer Research UK, we will continue to invest in research until we have delivered better diagnoses, better treatments and, ultimately, better quality of life for each one of them."

Explore further: Genetic screen finds new treatment targets for lung cancer

Related Stories

Genetic screen finds new treatment targets for lung cancer

July 9, 2013
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research ...

Lung cancer surgery survival rates unchanged since 1950s

November 20, 2013
No treatment for lung cancer today gives us significantly better chances of survival than chest surgery from 60 years ago, according to a medical historian from The University of Manchester.

Targeted treatment is better than chemotherapy in some lung cancer patients

January 13, 2014
(Medical Xpress)—Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according a study by University of Manchester scientists.

Simple protein test could improve prediction of survival rates for patients with head and neck cancer

January 24, 2014
(Medical Xpress)—Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - used a simple protein test that could prove more useful in predicting survival chances for patients with ...

Research backs risk-reduction surgery for ovarian cancer

December 17, 2013
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer because ...

Eight in 10 now survive skin cancer

July 22, 2013
(Medical Xpress)—More than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.